Clinical trial
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both…
NCT00186433 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186433 |
|---|---|
| Title | A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations |
| Official title | A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Mouth Cancer, Lip Cancer, Throat Cancer, Lip Neoplasms, Head and Neck Cancers |
| Enrollment | 49 |
| Start date | Nov 1, 2001 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Sep 16, 2005 |
| Last update posted | May 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: